Lever Bio
2 known investors
Lever Bio is an immuno-oncology company developing compounds that reprogram the solid tumor microenvironment to enhance the recruitment, activation, and function of cytotoxic T lymphocytes against solid tumors. It works with researchers, universities, and research centers to advance cancer immunotherapy drug development.
Investors · 2
Frequently asked questions
- What does Lever Bio do?
- Lever Bio is an immuno-oncology company developing compounds that reprogram the solid tumor microenvironment to enhance the recruitment, activation, and function of cytotoxic T lymphocytes against solid tumors. It works with researchers, universities, and research centers to advance cancer immunotherapy drug development.
- Who are Lever Bio's investors?
- Lever Bio's investors include Claris Ventures, Italian Angels for Growth.